The table below shows ABVC BIOPHARMA, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
$509.59K
$152.43K
$969.78K
$355.80K
$483.05K
Cost of revenue
-
$763.00
$302.04K
$286.42K
$5.09K
$18.72K
Gross profit
-
$508.83K
-$149.61K
$683.37K
$350.71K
$464.33K
R&D
$121.08K
$179.27K
$1.06M
$2.69M
$1.00M
$549.66K
ABVC annual revenue (10-K history)
ABVC BIOPHARMA, INC. reported annual revenue of $509.59K for fiscal year 2024. That is up 234.3% from $152.43K in fiscal 2023. Over the 10 fiscal years shown, annual revenue grew from $7.79K (FY 2013) to $509.59K. Figures come from the company's audited annual reports as filed with the SEC.